Approval · Notice of Compliance 6625 · 2005
RYLOSOL: Notice of Compliance 6625
Issued April 25, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6625
- Date
- April 25, 2005
- Company
- Valeant Canada LpLaval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Anti-arrhythmic
- Canadian reference product
- SOTACOR (Bristol Laboratories Of Canada)
Products in this notice
Medicinal ingredients
- SOTALOL HYDROCHLORIDE 80 MG per TAB
- SOTALOL HYDROCHLORIDE 160 MG per TAB
- SOTALOL HYDROCHLORIDE 240 MG per TAB